Entrada Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC TRDA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

221,269

Value ($000)

2,275

Weight

0.0%

2021 Q4 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,275	0.0%	221,269	12/31/2025
2025 Q3	11/10/2025	1,075	0.0%	185,259	9/30/2025
2025 Q2	8/12/2025	1,369	0.0%	203,693	6/30/2025
2025 Q1	9/15/2025	1,742	0.0%	192,717	3/31/2025
2024 Q4	2/6/2025	3,408	0.0%	197,127	12/31/2024
2024 Q3	11/12/2024	2,972	0.0%	185,984	9/30/2024
2024 Q2	8/12/2024	2,313	0.0%	162,341	6/30/2024
2024 Q1	5/9/2024	2,219	0.0%	156,629	3/31/2024
2023 Q4	2/6/2024	2,284	0.0%	151,358	12/31/2023
2023 Q3	11/8/2023	2,453	0.0%	155,224	9/30/2023
2023 Q2	8/10/2023	2,156	0.0%	142,417	6/30/2023
2023 Q1	5/12/2023	1,297	0.0%	89,478	3/31/2023
2022 Q4	2/13/2023	1,203	0.0%	88,970	12/31/2022
2022 Q3	11/14/2022	1,385	0.0%	87,859	9/30/2022
2022 Q2	8/15/2022	522	0.0%	42,782	6/30/2022
2022 Q1	5/13/2022	646	0.0%	68,704	3/31/2022
2021 Q4	2/11/2022	1,097	0.0%	64,019	12/31/2021